• Publications
  • Influence
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
TLDR
The aim was to examine the effect of glucagon-like peptide-1 on subsequent energy intake using a data set composed of subject data from previous studies and from two as yet unpublished studies, and investigate whether the effect on energy intake is dose dependent and differs between lean and overweight subjects.
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
TLDR
Intravenous infusions of GLP-1 enhance sodium excretion, reduce H+ secretion, and reduce glomerular hyperfiltration in obese men, suggesting an action at the proximal renal tubule and a potential renoprotective effect.
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
TLDR
A marked effect of GLP-1 on appetite is demonstrated by showing enhanced satiety and reduced energy intake in patients with diabetes type 2.
Glucagon-like peptide-1: a potent regulator of food intake in humans
TLDR
Intravenous infusions of GLP-1 decrease spontaneous food intake even at physiological plasma concentrations, implying an important role for GLp-1 in the regulation of the early satiety response in humans.
Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer
This study investigated whether nutritional risk scores applied at hospital admission predict mortality and complications after colorectal cancer surgery.
MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT
TLDR
Systematic site-specific expression of MDR1 and MRP mRNA along the gastrointestinal tract in humans is shown for the first time, and all transporters showed alterations in their expression levels from the duodenum to sigmoid colon.
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men.
TLDR
CCK and GLP-1 are meal-related satiety signals that are released from the gastrointestinal tract during food intake that reject the hypothesis that the two peptides exert a positive synergistic effect on food intake compared with the effects observed with infusion of individual peptides.
Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in Humans
TLDR
GLP-1 acts on renal tissue reducing sodium absorption, probably via similar sodium transporters, which also may be localized in the gastrointestinal tract, which needs to be confirmed by further studies.
Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
TLDR
There is a strong evidence that HDF has no advantage over HD with respect to urea and creatinine removal in vivo, however, HDF did improve the elimination of phosphate and should be considered as an additional treatment option for hyperphosphatemia in dialysis patients.
...
...